Banri Tsuda

502 total citations
27 papers, 333 citations indexed

About

Banri Tsuda is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Banri Tsuda has authored 27 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Banri Tsuda's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Banri Tsuda is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Banri Tsuda collaborates with scholars based in Japan and Italy. Banri Tsuda's co-authors include Yutaka Tokuda, Takuho Okamura, Yuki Saito, Naoki Niikura, Nobue Kumaki, Yasuhiro Suzuki, Yoshie Kametani, Takayuki Iwamoto, Risa Oshitanai and Rin Ogiya and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Banri Tsuda

25 papers receiving 330 citations

Peers

Countries citing papers authored by Banri Tsuda

Since Specialization

Citations

This map shows the geographic impact of Banri Tsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Banri Tsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Banri Tsuda more than expected).

Fields of papers citing papers by Banri Tsuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Banri Tsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Banri Tsuda. The network helps show where Banri Tsuda may publish in the future.

Co-authorship network of co-authors of Banri Tsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Banri Tsuda. A scholar is included among the top collaborators of Banri Tsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Banri Tsuda. Banri Tsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-progesterone environment preserves T cell competency by evading glucocorticoid effects on immune regulation 2022 ·Frontiers in Immunology ·(unknown), Toshiro Seki, (unknown), (unknown), (unknown), (unknown), (unknown), Yumiko Goto, Atsushi Yasuda, Banri Tsuda, Ryoji Ito, (unknown), Hitoshi Ishimoto, Takashi Shiina, Yoshie Kametani	7
2	Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression 2022 ·Scientific Reports ·Toru Hanamura, Shigehisa Kitano, Hiroshi Kagamu, Makiko Yamashita, (unknown), Banri Tsuda, Takuho Okamura, Nobue Kumaki, Katsuto Hozumi, Naoki Harada, Takayuki Iwamoto, Chikako Honda, Sasagu Kurozumi, Naoki Niikura	9
3	Correlation of preference- and profile-based quality of life of Japanese oral cancer patients during the perioperative period measured using EQ-5D-5L and FACT-H&N 2021 ·International Journal of Oral and Maxillofacial Surgery ·Takayuki Aoki, Yukihide Ota, (unknown), (unknown), (unknown), Banri Tsuda	1
4	HER2-antigen-specific humoral immune response in breast cancer lymphocytes transplanted in hu-PBL hIL-4 NOG mice 2021 ·Scientific Reports ·(unknown), (unknown), (unknown), Fuyuki Kametani, Ryoji Ito, Banri Tsuda, (unknown), (unknown), (unknown), Toshiro Seki, Atsushi Yasuda, Kiyoshi Ando, Mamoru Ito, Yutaka Tokuda, Yoshie Kametani	4
5	Taste alterations in patients with breast cancer following chemotherapy: a cohort study 2020 ·Breast Cancer ·(unknown), Naoki Niikura, Shizuko Satoh‐Kuriwada, (unknown), (unknown), (unknown), Banri Tsuda, Takuho Okamura, Yoshihide Ota, Yutaka Tokuda, Takashi Sasano, Noriaki Shoji	17
6	Distinction of IgG4-related mastitis from breast cancer: a case report 2019 ·SHILAP Revista de lepidopterología ·Banri Tsuda, Nobue Kumaki, (unknown), Mari Mizuno, (unknown), Risa Oshitanai, (unknown), (unknown), Takuho Okamura, Yuki Saito, Yasuhiro Suzuki, Naoki Niikura	8
7	Difficult Diagnosis of Peritoneal Serous Papillary Carcinoma in a 63-year-old Woman: A Case Report. 2019 ·PubMed ·Banri Tsuda, Hiroshi Kajiwara, (unknown), (unknown), (unknown), Masae Ikeda	1
8	Rare Finding of Bilateral Pseudoangiomatous Stromal Hyperplasia of the Breast: A Case Report. 2019 ·PubMed ·Banri Tsuda, Nobue Kumaki, (unknown), (unknown), (unknown), Mari Mizuno, (unknown), (unknown), (unknown), (unknown), Naoki Niikura	3
9	Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint Inhibitors 2019 ·International Journal of Molecular Sciences ·Yoshie Kametani, (unknown), (unknown), Banri Tsuda, Atsushi Yasuda, Toshiro Seki, Ryoji Ito, Yutaka Tokuda	23
10	Comparison of Ki-67 labeling index measurements using digital image analysis and scoring by pathologists 2018 ·Breast Cancer ·(unknown), Naoki Niikura, Nobue Kumaki, Shinobu Masuda, Takayuki Iwamoto, (unknown), Rin Ogiya, Risa Oshitanai, (unknown), Banri Tsuda, Takuho Okamura, Yuki Saito, Yasuhiro Suzuki, Yutaka Tokuda	2
11	B-cell populations are expanded in breast cancer patients compared with healthy controls 2017 ·Breast Cancer ·Banri Tsuda, (unknown), (unknown), Rin Ogiya, Risa Oshitanai, (unknown), (unknown), Naoki Niikura, Takuho Okamura, (unknown), Yuki Saito, Yasuhiro Suzuki, Yoshie Kametani, Yutaka Tokuda	22
12	NOG-hIL-4-Tg, a new humanized mouse model for producing tumor antigen-specific IgG antibody by peptide vaccination 2017 ·PLoS ONE ·Yoshie Kametani, Ikumi Katano, (unknown), Yusuke Kikuchi, Ryoji Ito, Yukari Muguruma, Banri Tsuda, Sonoko Habu, Yutaka Tokuda, Kiyoshi Ando, Mamoru Ito	17
13	B Cell Epitope-Based Vaccination Therapy 2015 ·SHILAP Revista de lepidopterología ·Yoshie Kametani, (unknown), Banri Tsuda, Yutaka Tokuda	13
14	Defect of tropomyosin-related kinase B isotype expression in ovarian clear cell adenocarcinoma 2014 ·BioScience Trends ·Yumiko Goto, Yoshie Kametani, (unknown), Banri Tsuda, Masaki Miyazawa, Hiroshi Kajiwara, Yasuhisa Terao, Susumu Takekoshi, Naoya Nakamura, Satoru Takeda, Mikio Mikami	2
15	Feasibility and pharmacokinetics of combined therapy with S-1 and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic or recurrent breast cancer 2013 ·International Journal of Clinical Oncology ·Yasuhiro Suzuki, Rin Ogiya, Risa Oshitanai, (unknown), (unknown), (unknown), Banri Tsuda, Naoki Niikura, Takuho Okamura, Yuki Saito, Yutaka Tokuda	4
16	Abstract P5-01-11: A new anti-HER2 peptide “CH401MAP” can stimulate the immunity of breast cancer patients 2013 ·Cancer Research ·Banri Tsuda, Yoshie Kametani, (unknown), Risa Oshitanai, Mineko Terao, Mitsuo Terada, (unknown), Naoki Niikura, Takashi Okamura, Yuya Saito, Yoshimasa Suzuki, Yutaka Tokuda	1
17	Immunohistochemical Ki67 labeling index has similar proliferation predictive power to various gene signatures in breast cancer 2012 ·Cancer Science ·Naoki Niikura, Takayuki Iwamoto, Shinobu Masuda, Nobue Kumaki, Xiaoyan Tang, Masatoshi Shirane, Kazushige Mori, Banri Tsuda, Takuho Okamura, Yuki Saito, Yasuhiro Suzuki, Yutaka Tokuda	39
18	Antitumor effect of new HER2 peptide vaccination based on B cell epitope. 2011 ·PubMed ·(unknown), Yoshie Kametani, Ikumi Katano, Ryoji Ito, Banri Tsuda, (unknown), Yuki Saito, Dai Ishikawa, Kōichi Ogino, Shigeru Sasaki, Kohzoh Imai, Sonoko Habu, Hiroyasu Makuuchi, Yutaka Tokuda	27
19	Post-marketing Safety Evaluation of S-1 in Patients with Inoperable or Recurrent Breast Cancer: Especially in Patients Treated with S-1 + Trastuzumab 2011 ·Japanese Journal of Clinical Oncology ·Yuki Saito, Risa Oshitanai, Mineko Terao, (unknown), Banri Tsuda, Takuho Okamura, Yuji Suzuki, Yasuharu Tokuda	3
20	Trastuzumab and chemotherapy after the treatment failure of lapatinib for HER2-positive metastatic breast cancer. 2010 ·PubMed ·Yasuhiro Suzuki, Yuki Saito, (unknown), (unknown), (unknown), Banri Tsuda, Takuho Okamura, Naoki Niikura, Yutaka Tokuda	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact